Summary
Nick Simmonds is Professor of Practice (Respiratory Medicine) at the National Heart and Lung Institute (NHLI), Imperial College London and Associate Director of the Adult CF Centre at the Royal Brompton Hospital, London. His main research interests include difficult CF diagnosis and the investigation of novel CF therapies. He has been a Principal Investigator on numerous global multicentre trials and is on the Executive Committee of the European Cystic Fibrosis Society (ECFS) Clinical Trials Network. He has extensive experience of novel diagnostic techniques and is the Vice Coordinator of the ECFS Diagnostic Network. He is also on the Registry Research Committee of the UK CF Registry, a role which promotes the use of registries to better understand outcomes in CF.
Publications
Journals
De Wachter E, Davies JC, Simmonds NJ, et al., 2023, Letter to the editor: Risk of false newborn screening after intra-uterine exposure to ETI., J Cyst Fibros
Middleton PG, Simmonds NJ, 2023, Cystic fibrosis modulator therapy can reverse cystic bronchiectasis., Respirol Case Rep, Vol:11, ISSN:2051-3380
Cameron RA, Rowley M, Simmonds NJ, et al., 2023, Response., Chest, Vol:163, Pages:e194-e195
Davies J, Hughes D, Rosenthal M, et al., 2023, An invisible threat? Aspergillus positive cultures and co-infecting bacteria in airway sample, Journal of Cystic Fibrosis, Vol:22, ISSN:1569-1993, Pages:320-326
Barry PJJ, Simmonds NJJ, 2023, Diagnosing Cystic Fibrosis in Adults, Seminars in Respiratory and Critical Care Medicine, ISSN:1069-3424